Endo Pharmaceuticals’ (JOBS) AIDS Virus “Prevention” Gel Fails in African Trials

Bookmark and Share

Reuters -- U.S. drug firm Endo Pharmaceuticals' gel designed to prevent infection with the AIDS virus has proved ineffective in trials in Africa, Britain's Medical Research Council (MRC) said on Monday.
MORE ON THIS TOPIC